SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-120472
Filing Date
2022-04-26
Accepted
2022-04-26 17:13:08
Documents
12
Period of Report
2022-04-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d283150d8k.htm   iXBRL 8-K 26913
  Complete submission text file 0001193125-22-120472.txt   149303

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA evok-20220426.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20220426_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20220426_pre.xml EX-101.PRE 11270
6 EXTRACTED XBRL INSTANCE DOCUMENT d283150d8k_htm.xml XML 3447
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 22855331
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences